<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01316497</url>
  </required_header>
  <id_info>
    <org_study_id>20080052</org_study_id>
    <nct_id>NCT01316497</nct_id>
  </id_info>
  <brief_title>Acute Kidney Injury in Children Operated for Congenital Heart Disease</brief_title>
  <official_title>Acute Kidney Injury in Children Operated for Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aase and Ejnar Danielsens Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Augustinus Foundation, Denmark.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Direktør Kurt Bønnelycke and Hustru fru Grethe Bønnelyckes Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helen and Ejnar Bjørnows Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Raimond and Dagmar Ringgård-Bohn's Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Grosserer L.F. Foghts Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Snedkermester Sophus Jacobsen and hustru Astrid Jacobsens Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Dagmar Marshall Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to investigate if repeated inflation of a blood pressure cuff
      applied around one leg causing mild ischemia (&quot;remote ischemic preconditioning&quot;) could
      protect children operated for congenital heart disease from developing acute kidney injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Remote ischemic preconditioning (RIPC) refers to an intervention of remote, brief ischemia
      which confers systemic protection against consequences of reperfusion injury in distant
      organs. RIPC has been shown to protect various organs during major surgeries. Our hypothesis
      was that RIPC could protect kidney function in children operated for complex congenital heart
      disease.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute kidney injury</measure>
    <time_frame>Up to 4 days</time_frame>
    <description>Categorized according to the RIFLE criteria (22): R= risk= increased p-creatinine * 1.5 and/or urine output &lt; 0.5 ml/kg/hour for 6 hours, I= injury= increased p-creatinine * 2 and/or urine output &lt; 0.5 ml/kg/hour for 12 hours, F= failure= increased p-creatinine * 3 or p-creatinine ≥ 350 µmol/L in the setting of an acute increase of at least 44 µmol/L and/or urine output &lt; 0.3 ml/kg/hour for 24 hours or anuria for 12 hours, L= complete loss of renal function for &gt; 4 weeks (need for dialysis for longer than 4 weeks), E= end-stage renal disease (need for dialysis for longer than 3 months).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial blood pressure</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>Incidence of postoperative low blood pressure (below the age-reference level)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inotropic Score (IS)</measure>
    <time_frame>Up to 3 days</time_frame>
    <description>The highest postoperative daily dose (µg/kg//min) was used in the formula: IS = [(dopamine + dobutamine) × 1] + (milrinone × 10) + [(epinephrine + norepinephrine) × 100] to calculate the IS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperation during hospital stay</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay at the ICU</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>90 days</time_frame>
    <description>In-hospital mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of cystatin C in plasma</measure>
    <time_frame>Up to 4 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Neutrophil Gelatinase-Associated Lipocalin in plasma and urine</measure>
    <time_frame>Up to 4 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Remote ischemic preconditioning (RIPC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>See intervention description</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote ischemic preconditioning (RIPC)</intervention_name>
    <description>RIPC was performed by applying a blood pressure cuff around the child's leg. The cuff was inflated to 40 mmHg above the systolic pressure in 4 cycles of 5 minutes. Every cycle of ischemia was followed by 5 minutes of reperfusion. The first RIPC cycle started after anesthesia induction when invasive arterial blood pressure was monitored. Appropriate cuff size was used choosing between four sizes. For reproducibility RIPC was performed on the right leg with only a few exceptions, when the leg was used for invasive catheters.</description>
    <arm_group_label>Remote ischemic preconditioning (RIPC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>The cuff was applied on the leg without inflation in the control group.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children admitted for surgery for congenital heart disease

        Exclusion Criteria:

          -  heart surgeries of low complexity such as closure of septal defects, aortico-pulmonary
             windows, establishment of glenn shunts, subaortic membrane resection, redirection of
             anomalous pulmonary veins, valvotomies, repair of pulmonary artery stenosis and
             surgeries without the use of extracorporeal circulation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kirsten MR Pedersen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Skejby</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vibeke E Hjortdal, MD PhD DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Skejby</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hanne B Ravn, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesia and Intensive Care, Aarhus University Hospital, Skejby</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johan V Povlsen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Renal Medicine C, Aarhus University Hospital, Skejby</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael R Schmidt, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Erland Erlandsen, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Clinical Biochemistry, Viborg Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Skejby</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Pedersen KR, Povlsen JV, Christensen S, Pedersen J, Hjortholm K, Larsen SH, Hjortdal VE. Risk factors for acute renal failure requiring dialysis after surgery for congenital heart disease in children. Acta Anaesthesiol Scand. 2007 Nov;51(10):1344-9.</citation>
    <PMID>17944638</PMID>
  </reference>
  <reference>
    <citation>Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol. 2006 Jun 6;47(11):2277-82. Epub 2006 May 15.</citation>
    <PMID>16750696</PMID>
  </reference>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2011</study_first_submitted>
  <study_first_submitted_qc>March 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2011</study_first_posted>
  <last_update_submitted>September 13, 2012</last_update_submitted>
  <last_update_submitted_qc>September 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute kidney injury</keyword>
  <keyword>Ischemic preconditioning</keyword>
  <keyword>Congenital heart defects</keyword>
  <keyword>Cardiac surgical procedures</keyword>
  <keyword>Infant</keyword>
  <keyword>Child</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

